Cervical Cancer GOG 127W

March 13, 2013

Location: The Hospital of Central Connecticut

A Phase II Evaluation Of ABT-888, Topotecan And Filgrastim Or Pegfilgrastim In The Treatment Of Persistent Or Recurrent Squamous Or Non-Squamous Cell Carcinoma Of The Cervix.

Connect With Us

Subscribe to Our Newsletters

Get the latest healthcare news directly in your inbox.

Hartford HealthCare Offices

One State Street, Suite 19, Hartford, CT 06103 • Contact Us

Donations to Hartford HealthCare are managed by the Hartford Hospital Department of Philanthropy, a Connecticut tax-exempt organization under section 501(c)(3) of the IRS code (E.I.N. 06-0646668). For more information, click here.